Subsequently, function analysis revealed that inhibition of LPA3 by shRNA or antagonist dramatically suppressed the migration and invasion ability of TNBC cells, but had no or less effect on normal or luminal-type cancer cells, which suggests a role for LPA3 in the pathophysiology of TNBCs. This evidence concerns the gene LPAR3 and cancer.